fibrinogen has been researched along with Dyspnea in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barrecheguren, M; Esquinas, C; Gava, G; Loeb, E; Miravitlles, M; Núñez, A; Pirina, P; Sarasate, M | 1 |
| Adami, G; Benini, C; Bertoldo, E; Bertoldo, F; Fassio, A; Gatti, D; Giannini, S; Giollo, A; Idolazzi, L; Micheletto, C; Orsolini, G; Passeri, G; Rossini, M; Tacconelli, E; Viapiana, O | 1 |
| Alber, HF; Dörler, J; Edlinger, M; Steyerberg, EW; Ulmer, H; Wanitschek, M | 1 |
| Guo, F; Yang, Z; Yu, Y; Zhu, Y | 1 |
| Centanni, S; Di Marco, F; Pellegrino, GM; Pontiroli, AE; Repossi, AC; Roggi, MA; Santus, P; Terraneo, S; Veronelli, A | 1 |
| Hanania, NA; Lavoie, K; Müllerová, H; Rennard, SI; Tal-Singer, R; Vestbo, J; Wouters, EF; Yohannes, AM | 1 |
| Daniil, ZD; Germenis, A; Gourgoulianis, KI; Kiropoulos, TS; Kostikas, K; Koutsokera, A; Nikoulis, DJ; Papaioannou, AI; Tanou, K; Tsolaki, V | 1 |
| Coffin, R; Droulle, C; Jacotot, T; Leroux, B; Potron, G; Roussel, B | 1 |
| Berman, L; Dolovich, J; Gibson, P; Gleich, GJ; Hargreave, FE; Parameswaran, K; Pizzichini, E; Pizzichini, MM | 1 |
| Gurewich, V | 1 |
1 review(s) available for fibrinogen and Dyspnea
| Article | Year |
|---|---|
Pulmonary thromboembolism.
Topics: Airway Obstruction; Angiography; Animals; Anticoagulants; Dyspnea; Electrocardiography; Fibrin; Fibrinogen; Fibrinolytic Agents; Heart Auscultation; Heparin; Humans; Ligation; Pulmonary Artery; Pulmonary Embolism; Radionuclide Imaging; Thrombophlebitis; Vena Cava, Inferior | 1973 |
1 trial(s) available for fibrinogen and Dyspnea
| Article | Year |
|---|---|
Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Blood Proteins; Bronchitis; Chronic Disease; Cross-Over Studies; Dyspnea; Eosinophil Granule Proteins; Eosinophilia; Female; Fibrinogen; Follow-Up Studies; Forced Expiratory Volume; Forecasting; Glucocorticoids; Humans; Inflammation Mediators; Male; Middle Aged; Placebos; Prednisone; Quality of Life; Reproducibility of Results; Ribonucleases; Single-Blind Method; Smoking; Sputum | 1998 |
8 other study(ies) available for fibrinogen and Dyspnea
| Article | Year |
|---|---|
Analysis of Blood Biomarkers in Patients with Chronic Obstructive Pulmonary Disease (COPD) and with Asthma-COPD Overlap (ACO).
Topics: Aged; Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome; Biomarkers; C-Reactive Protein; Dyspnea; Eosinophilia; Eosinophils; Female; Fibrinogen; Forced Expiratory Volume; Humans; Leukocyte Count; Lymphocyte Count; Male; Middle Aged; Neutrophils; Platelet Count; Pulmonary Disease, Chronic Obstructive; Vital Capacity | 2020 |
Vitamin D and disease severity in coronavirus disease 19 (COVID-19).
Topics: Adult; Aged; Aged, 80 and over; C-Reactive Protein; Comorbidity; COVID-19; Disease Susceptibility; Dyspnea; Female; Fibrinogen; Humans; Italy; Length of Stay; Male; Middle Aged; Oxygen; Partial Pressure; Prevalence; Respiration, Artificial; Retrospective Studies; Severity of Illness Index; Vitamin D; Vitamin D Deficiency | 2021 |
External validation and extension of a diagnostic model for obstructive coronary artery disease: a cross-sectional predictive evaluation in 4888 patients of the Austrian Coronary Artery disease Risk Determination In Innsbruck by diaGnostic ANgiography (CA
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Austria; C-Reactive Protein; Chest Pain; Cholesterol, HDL; Cholesterol, LDL; Cohort Studies; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Cross-Sectional Studies; Dyspnea; Female; Fibrinogen; Humans; Logistic Models; Male; Middle Aged; Prospective Studies; Reproducibility of Results; Risk Assessment; Risk Factors; ROC Curve; Young Adult | 2017 |
Successful recovery from delayed amniotic fluid embolism.
Topics: Adult; Delivery, Obstetric; Dyspnea; Embolism, Amniotic Fluid; Erythrocyte Transfusion; Female; Fibrinogen; Humans; Plasma; Pregnancy; Resuscitation; Time Factors; Treatment Outcome; Uterine Hemorrhage | 2019 |
Physical activity impairment in depressed COPD subjects.
Topics: Accelerometry; Aged; Anaerobic Threshold; C-Reactive Protein; Depression; Dyspnea; Electric Impedance; Exercise Test; Female; Fibrinogen; Humans; Inflammation; Male; Middle Aged; Motor Activity; Nutritional Status; Obesity; Psychiatric Status Rating Scales; Pulmonary Disease, Chronic Obstructive; Quality of Life | 2014 |
Long-term Course of Depression Trajectories in Patients With COPD: A 3-Year Follow-up Analysis of the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints Cohort.
Topics: Adult; Aged; Biomarkers; C-Reactive Protein; Chemokines, CC; Cohort Studies; Depression; Depressive Disorder; Disease Progression; Dyspnea; Exercise Test; Fatigue; Female; Fibrinogen; Humans; Logistic Models; Longitudinal Studies; Male; Middle Aged; Odds Ratio; Pulmonary Disease, Chronic Obstructive; Pulmonary Surfactant-Associated Protein D; Sex Factors; Stroke; Uteroglobin | 2016 |
Clinical, functional and biochemical changes during recovery from COPD exacerbations.
Topics: Aged; Biomarkers; C-Reactive Protein; Disease Progression; Dyspnea; Female; Fibrinogen; Forced Expiratory Volume; Hospitalization; Humans; Interleukin-6; Male; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Quality of Life; Serum Amyloid A Protein; Severity of Illness Index; Time Factors; Tumor Necrosis Factors; Vital Capacity | 2009 |
[Thrombosis of the renal veins in a premature infant. Treatment with heparin and urokinase].
Topics: Acute Disease; Anticoagulants; Combined Modality Therapy; Cyanosis; Dehydration; Diarrhea, Infantile; Dyspnea; Factor V; Factor VII; Factor X; Female; Fibrinogen; Follow-Up Studies; Heparin; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases; Peritoneal Dialysis; Plasminogen; Renal Veins; Thrombolytic Therapy; Treatment Outcome; Urokinase-Type Plasminogen Activator; Venous Thrombosis | 1976 |